PUBLICATIONS - New from Clinica Reports - Commercial Opportunities for Biochips and Microarrays
This article was originally published in Clinica
Executive Summary
How many people can you fit in a bus? In 2002 the record stood at 110 people, which was achieved in London in October 2000. A simpler question might appear to be: "How many laboratories can you fit on a bus?" The obvious answer would be somewhere in the region of one or two, but in 2002 the answer is literally thousands. This is because operations that a mere decade ago would have been performed using large, labour intensive technologies have now been miniaturised so that they can be performed on a platform not much bigger than the size of a postage stamp. These miniaturised technologies are called biochips and microarrays.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.